CYTOSAR Solution sol inj 100 mg/5ml Onco-Tain 5 ml
7680548450142
CH-54845
L01BC01
07.16.1.
1 / 3
google
Details
- Product number
- 5484501
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- cytarabinum 100 mg, natrii chloridum corresp. natrium 13.39 mg, acidum hydrochloridum q.s. ad pH, natrii hydroxidum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 5 ml.
Articles (1)
Cytosar Solution 100 mg/5 ml, Injektionslöung
Lösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
13.39 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 13.10
Specialties list
Yes
Generic
No
SL addition date:
01/10/2015
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 54845
- Drug name
- Cytosar Solution, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- L01BC01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 15/12/1999
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CYTOSAR Solution sol inj 100 mg/5ml Onco-Tain 5 ml
- Description (DE)
- CYTOSAR Solution Inj Lös 100 mg/5ml Onco-Tain 5 ml
- Market launch
- 15/12/1999
- Narcotic (BTM)
- No